Brief: Onxeo introduces chemistry platform of decoy oligonucleotides platON
Oct 2 (Reuters) - ONXEO SA C4X.PA :
* ONXEO INTRODUCES PLATON, A PROPRIETARY CHEMISTRY PLATFORM
OF DECOY OLIGONUCLEOTIDES
* PLATON WILL GENERATE NEW BEST-IN-CLASS DNA-TARGETING
DRUG CANDIDATES STARTING IN 2018
Source text for Eikon: ID:nBw6MqmNPa
Further company coverage: C4X.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln